El Hajjar, Abdel Hadi
Dagher, Lilas
Younes, Hadi
Mekhael, Mario
Noujaim, Charbel
Chouman, Nour
Greene, Tom
Pandey, Amitabh C.
Huang, Chao
Marrouche, Nassir
Article History
Received: 12 March 2024
Accepted: 28 May 2024
First Online: 18 July 2024
Declarations
:
: NM reports having received consulting fees from Biosense Webster, Boston Scientific, and AtriCure. NM also reports being a speaker for Abbott, Biosense Webster, AtriCure, and Sanofi. NM also reports receiving research support Abbott, Medtronic, Biosense Webster, Siemens, GE, Boston Scientific, Sanofi, and Samsung. NM also reports having a family member as the CEO of Cardiac Designs. NM also reports being the founder of Marrek, being named in a patent issued for MRI fibrosis imaging, and being a previous shareholder of Cardiac Designs. All other co-authors have no relevant conflict of interest. The DECAAF II trial was funded by Medtronic, GE, Siemens, Boston Scientific, Biosense Webster, and Abbott.